Parallax Volatility Advisers, L.P. Glaukos Corp Call Options Transaction History

Parallax Volatility Advisers, L.P.

3 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2021 Nov 15, 2021	BUY	$47.43 - $84.23 $2.34 Million - $4.15 Million	49,300 New	49,300 $2.38 Million
Q2 2018 Aug 14, 2018	SELL	$27.62 - $44.51 $552,400 - $890,200	-20,000 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$31.26 - $42.03 $625,200 - $840,600	20,000	20,000 $660,000

340

47.1M

132K

188K

Ticker GKOS
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 47,596,900
Market Cap $6.85B
Description
Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-...

Get notified when there are updates to the investment portfolio of Parallax Volatility Advisers, L.P., based on Form 13F filings with the SEC.

Stay updated on Parallax Volatility Advisers, L.P. with notifications on news.